Apyx Medical Corp APYX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if APYX is a good fit for your portfolio.
News
-
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024
-
Apyx Medical Corporation Launches the "Renewing Lives" Give-Back Campaign Providing Treatments with Renuvion to Benefit Physical Appearance and Mental Health
-
Apyx Medical Corporation Reports First Quarter 2024 Financial Results; Reaffirms Full Year 2024 Financial Outlook
-
Apyx Medical Corporation Announces Board Leadership Transition
Trading Information
- Previous Close Price
- $1.41
- Day Range
- $1.32–1.39
- 52-Week Range
- $1.21–5.82
- Bid/Ask
- $1.33 / $1.35
- Market Cap
- $46.42 Mil
- Volume/Avg
- 35,453 / 49,866
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.93
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 252
- Website
- https://apyxmedical.com
Comparables
Valuation
|
Metric
|
APYX
|
MMSI
|
EMBC
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 27.25 | 4.54 |
Price/Book Value | 2.31 | 4.01 | — |
Price/Sales | 0.93 | 3.90 | 0.80 |
Price/Cash Flow | — | 21.91 | 8.15 |
Price/Earnings
APYX
MMSI
EMBC
Financial Strength
|
Metric
|
APYX
|
MMSI
|
EMBC
|
|---|---|---|---|
Quick Ratio | 4.71 | 4.22 | 1.50 |
Current Ratio | 5.87 | 6.03 | 2.29 |
Interest Coverage | −5.70 | 6.17 | 1.45 |
Quick Ratio
APYX
MMSI
EMBC
Profitability
|
Metric
|
APYX
|
MMSI
|
EMBC
|
|---|---|---|---|
Return on Assets (Normalized) | −30.68% | 9.17% | 12.15% |
Return on Equity (Normalized) | −65.91% | 15.14% | — |
Return on Invested Capital (Normalized) | −33.22% | 10.93% | 28.15% |
Return on Assets
APYX
MMSI
EMBC
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Rynkspk | Fwqgsrb | $183.1 Bil | |||
| Stryker Corp
SYK
| Jpxtsprw | Rnkf | $126.3 Bil | |||
| Boston Scientific Corp
BSX
| Jddghpwq | Xqgbqvt | $110.1 Bil | |||
| Medtronic PLC
MDT
| Hyqpdzl | Ncvyysz | $100.9 Bil | |||
| Edwards Lifesciences Corp
EW
| Sjgvqxbntz | Sgbdbw | $37.6 Bil | |||
| DexCom Inc
DXCM
| Xvphrgnjlq | Hvcv | $25.6 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Tfjqlytn | Jcntjf | $24.1 Bil | |||
| Steris PLC
STE
| Lgcrxsfp | Djvrjn | $23.0 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Hmwzjwjtkz | Yrcxh | $22.9 Bil | |||
| Align Technology Inc
ALGN
| Kmlyqcp | Crvnpn | $16.6 Bil |